Brokerages Expect HCA Healthcare Inc (HCA) Will Post Earnings of $2.58 Per Share

Equities research analysts expect that HCA Healthcare Inc (NYSE:HCA) will post earnings per share of $2.58 for the current fiscal quarter, according to Zacks. Ten analysts have provided estimates for HCA Healthcare’s earnings, with the highest EPS estimate coming in at $2.68 and the lowest estimate coming in at $2.46. HCA Healthcare posted earnings of $2.12 per share in the same quarter last year, which would indicate a positive year-over-year growth rate of 21.7%. The business is expected to issue its next quarterly earnings report on Tuesday, January 29th.

According to Zacks, analysts expect that HCA Healthcare will report full-year earnings of $9.34 per share for the current financial year, with EPS estimates ranging from $9.23 to $9.38. For the next financial year, analysts expect that the company will report earnings of $10.11 per share, with EPS estimates ranging from $9.39 to $10.50. Zacks Investment Research’s EPS averages are an average based on a survey of sell-side research analysts that follow HCA Healthcare.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Tuesday, October 30th. The company reported $2.16 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.93 by $0.23. HCA Healthcare had a net margin of 6.82% and a negative return on equity of 73.71%. The firm had revenue of $11.45 billion for the quarter, compared to analysts’ expectations of $11.29 billion. During the same quarter in the previous year, the company earned $1.13 earnings per share. The company’s revenue for the quarter was up 7.1% compared to the same quarter last year.

A number of equities analysts have issued reports on the stock. SunTrust Banks boosted their price objective on shares of HCA Healthcare to $150.00 and gave the company a “positive” rating in a research report on Tuesday, September 4th. Leerink Swann boosted their price objective on shares of HCA Healthcare from $140.00 to $150.00 and gave the company an “outperform” rating in a research report on Tuesday, September 4th. Argus boosted their price objective on shares of HCA Healthcare to $150.00 and gave the company a “buy” rating in a research report on Friday, September 7th. Credit Suisse Group boosted their price objective on shares of HCA Healthcare from $156.00 to $165.00 and gave the company an “outperform” rating in a research report on Thursday, November 1st. Finally, Zacks Investment Research upgraded shares of HCA Healthcare from a “hold” rating to a “buy” rating and set a $151.00 price objective on the stock in a research report on Monday, November 26th. Two equities research analysts have rated the stock with a sell rating, five have assigned a hold rating and sixteen have given a buy rating to the stock. The company presently has a consensus rating of “Buy” and an average target price of $144.15.

HCA stock opened at $143.99 on Monday. HCA Healthcare has a 12-month low of $77.76 and a 12-month high of $145.74. The stock has a market capitalization of $49.56 billion, a price-to-earnings ratio of 21.85, a PEG ratio of 1.26 and a beta of 0.51.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 28th. Shareholders of record on Monday, December 3rd will be issued a $0.35 dividend. This represents a $1.40 dividend on an annualized basis and a yield of 0.97%. The ex-dividend date of this dividend is Friday, November 30th. HCA Healthcare’s dividend payout ratio (DPR) is presently 21.24%.

In other HCA Healthcare news, SVP Deborah M. Reiner sold 723 shares of the company’s stock in a transaction dated Monday, November 5th. The shares were sold at an average price of $135.06, for a total value of $97,648.38. Following the sale, the senior vice president now owns 6,184 shares in the company, valued at $835,211.04. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, SVP Jane D. Englebright sold 5,081 shares of the company’s stock in a transaction that occurred on Friday, November 9th. The stock was sold at an average price of $141.90, for a total transaction of $720,993.90. Following the completion of the transaction, the senior vice president now owns 16,504 shares in the company, valued at approximately $2,341,917.60. The disclosure for this sale can be found here. In the last 90 days, insiders sold 16,763 shares of company stock worth $2,346,147. Corporate insiders own 2.80% of the company’s stock.

Several hedge funds and other institutional investors have recently modified their holdings of the company. Vanguard Group Inc. lifted its stake in shares of HCA Healthcare by 0.3% in the third quarter. Vanguard Group Inc. now owns 19,916,360 shares of the company’s stock worth $2,770,765,000 after buying an additional 66,808 shares in the last quarter. Morgan Stanley lifted its position in HCA Healthcare by 28.1% during the third quarter. Morgan Stanley now owns 380,244 shares of the company’s stock valued at $52,900,000 after purchasing an additional 83,480 shares during the period. Kepos Capital LP bought a new position in HCA Healthcare during the third quarter valued at approximately $7,290,000. Rehmann Capital Advisory Group lifted its position in HCA Healthcare by 12,665.9% during the third quarter. Rehmann Capital Advisory Group now owns 21,702 shares of the company’s stock valued at $156,000 after purchasing an additional 21,532 shares during the period. Finally, Beaton Management Co. Inc. bought a new position in HCA Healthcare during the third quarter valued at approximately $257,000. Hedge funds and other institutional investors own 69.94% of the company’s stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

Recommended Story: Trading Penny Stocks

Get a free copy of the Zacks research report on HCA Healthcare (HCA)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply